Insilico Medicine

Upcoming Webinar Announcement 📢 IMGAIA: How AI Can Help Researchers Without a doubt AI is getting powerful. But how can we make it helpful？ At Insilico Medicine, we are committed to developing breakthrough products powered by #generativeAI and applying them to all aspects of life sciences to accelerate drug discovery, empower anti-aging research and support sustainable development. On July 23, 2pm EDT in a Virtual Launch Event, Insilico is going to unveil three innovative in-house developed #AI products for researchers and introduce the updates of Pharma.AI, its proprietary generative AI driven platform for early drug research. In addition, Insilico will introduce the advanced sustainable initiative driven by AI. √ PandaOmics Box, an AI-powered converged research platform, for localized biological research in target identification, #biomarker discovery and indication prioritization. √ DORA, an advanced large language model-driven AI assistant, designed to streamline the process of drafting #academic papers and other related documents. √ Precious-3 GPT, a transformer-based #LLM engine across multi-modal, multi-omics, multi-species for biomedical research through omics data generation and interpretation. Together, we're exploring how AI can help #lifescience researchers accomplish all their tasks more easily and efficiently. During the webinar you'll be able to get FREE access to DORA, the LLM-based paper writing assistant. We look forward to seeing you "virtually" soon! For the detailed agenda, please visit: https://lnkd.in/eVH6nGmd

How Insilico Medicine Deployed #GenerativeAI One inspiring example comes from Insilico Medicine, a biotech company and member of NVIDIA’s Inception program, which supplies cutting-edge AI training and support. Insilico used generative AI methods and NVIDIA technology to develop a drug to treat idiopathic pulmonary fibrosis – a relatively #raredisease that causes progressive decline in lung function. Using traditional methods, this process would have cost more than $400 million and taken up to six years. But thanks to generative AI, NVIDIA says Insilico accomplished the task for one-tenth of the cost and one-third of the time, proceeding to clinical trials in just two and a half years. What we’re talking about, then, is quicker cures for diseases. And for a fraction of the cost. Read more about this groundbreaking collaboration and its impact on the future of #healthcare: https://lnkd.in/eD6QU_n9 #AI #DrugDiscovery #Biotechnology #InsilicoMedicine #NVIDIA #HealthcareInnovation #GenerativeAI

In this episode of Boston Consulting Group (BCG)'s Health Tech Series, we discuss the challenges and progress in preventing #chronicdiseases, the growing trend of self-paying for aesthetic treatments with significant health implications, and the roles of companies and policymakers in advancing health care. BCG's Michael Ringel speaks with Alex Zhavoronkov, Founder and CEO at Insilico Medicine and Founder and Co-Chair of the Aging Research and Drug Discovery Conference, and Andrew Scott, author of "The 100 Year Life", Co-Founder of the Longevity Forum and Professor of Economics at the London Business School. View the full episode here: https://lnkd.in/e36DU43u #longevity #disease #healthcare

We are delighted to recognize and celebrate the exceptional talent of Junyue Wang, Columbia University, the winner of our Docuthon competition, for her remarkable documentary, "Exploring the Future of Medicine"! “This is not just a story about technological advancement; it’s about changing and saving lives. I hope this documentary will provoke deeper reflections on the integration of #AI with the #pharmaceutical industry and raise awareness of the immense potential and value of technology in the healthcare sector,” said Junyue Wang, who recently graduated from the film program at Columbia University. Taryn Southern, one of the judges, commented on this piece: “Excellent storytelling and pacing. Love the focus not just on the science, but on why this work matters for humanity, which captures the attention of a general audience. Also, did a great job of curating the best clips/material to convey the themes.” We extend our heartfelt gratitude to Junyue Wang for her dedication, creativity, and invaluable contribution to the Docuthon. Her work not only highlights the profound impact of AI in medicine but also sets a new benchmark for future storytellers. Congratulations once again on this well-deserved recognition! @Taryn Southern Amelia Martyn Hemphill Alvaro Alvarez Ricciardelli Laila Kazmi Oren Rosenfeld @Kai-Fu Lee Alexander Schuhmacher Michael Levitt @Peter H. Diamandis Alán Aspuru-Guzik Marek Piotrowski L/A Shari Marine Kinga Rajzak Beth Murphy Mariia Borsuk Chris Caurla @Maria Entraigues Abramson @Jess Blair Tom Popper #medicine #storytelling #pharma #drugdiscovery

Case Study: Insilico Medicine’s First #GenerativeAI Drug Discovery In June 2023, Insilico administered the first dose of INS018_055 to patients in a Phase II clinical trial. This drug's discovery marked a historic moment as the world’s first anti-fibrotic small molecule inhibitor was discovered and designed using generative AI. The success of INS018_055 validates the efficiency of generative AI in accelerating drug discovery and highlights its potential to tackle complex diseases. Read the full study here: https://lnkd.in/gT9g3eYv #drugdiscovery #clinicaltrials #smallmolecules

While the use of generative artificial intelligence (AI) to develop new medicines may be one of the most exciting breakthroughs of our AI-enabled world, it’s still a relatively unknown story. Docuthon, a documentary hackathon, is designed to share the story of how that transformation happened through the lens of Insilico, an early pioneer in the industry. Today, we're excited to share "Coding the Impossible Cure," a documentary produced by Insilico's internal team as part of the Docuthon competition, which captured the journey of Insilico’s first AI discovered and developed program from algorithms to Phase II. It aims to motivate people both within and outside our field to work towards a universal goal: boosting healthier and longer quality-lifetimes for humanity with the power of #generativeAI.  This documentary is based on a paper we published in February, detailing our achievements in using AI for drug discovery.  https://lnkd.in/gWd_UZ_6 We are also proud to announce that Insilico Medicine has nominated the winners of the Docuthon after receiving more than 90 submissions from 14 countries with a wide range of perspectives. We've reviewed them in parallel with an internal working group and external professional judging panel. We want to express our sincere gratitude to all the participants, partners, and judges Alvaro Alvarez Ricciardelli Oren Rosenfeld Laila Kazmi Taryn Southern Amelia Martyn Hemphill. Looking forward to sharing more winning videos in the following days. #Innovation #AI #DrugDiscovery #ClinicalTrials #Docuthon #InsilicoMedicine #GenerativeAI #AIDD #CodingTheImpossibleCure

Insilico Medicine launched PandaOmics about two years ago. Since then, the platform has been tried by thousands of users. And Insilico continues to find ways to expand PandaOmics’ capabilities. Some of its expansion plans emerge from interactions with academics, Zhavoronkov says. In fact, PandaOmics was inspired in part by the work of Open Targets, a consortium of academic and #pharmaceutical partners that developed an open AI-based platform for identifying and prioritizing #drugtargets. “If the community comes up with ideas and we see that one of its methods is interesting,” Zhavoronkov points out, “we add it to the platform with the requisite permission.” Continue Reading from Genetic Engineering & Biotechnology News: https://lnkd.in/eM9TDXCs

Upcoming Event Announcement! To respond to the fast-evolving global landscape, the World Economic Forum will convene the 15th Annual Meeting of the New Champions in Dalian, People’s Republic of China, on 25-27 June 2024. The event will gather over 1,500 high-level leaders from business, government, civil society and international organizations, as well as prominent entrepreneurs, innovators and academics to generate collective insights and deployable solutions. This meeting in Asia, a region that continues to drive two-thirds of all global growth, will enable leaders to collaborate and foster ways to spur and maintain positive economic momentum. Learn more here: https://bit.ly/4batYcn

We are thrilled to announce that the special award in our documentary competition goes to the inspiring all-girl robotics team from Afghanistan, known as “The Afghan Dreamers.” Their exceptional video about Insilico Medicine���s robotics lab stood out for its creativity, dedication, and vision. The Afghan Dreamers have showcased the incredible potential of young minds and the importance of fostering innovation and scientific curiosity. We hope their story encourages more young people to explore the exciting possibilities in robotics and AI. Congratulations to The Afghan Dreamers! Keep dreaming and pushing the boundaries of what’s possible. https://lnkd.in/eY3JU2uw #Innovation #AI #Robotics #HealthyLongevity #YouthEmpowerment #InsilicoMedicine #AfghanDreamers

Congratulations! After receiving more than 90 submissions from 14 countries with a wide range of perspectives, and reviewing them in parallel by an internal working group and external professional judges, we are thrilled to nominate the winners of the Docuthon, a documentary hackathon initiated by the company aimed at raising awareness of AI in drug discovery through scientific storytelling. As a pioneering entity in the AIDD industry, Insilico Medicine has achieved numerous milestones, faced crises, welcomed new talents, and navigated both successful launches and project terminations. However, the general public remains largely unaware of the challenges and enormous costs involved in drug development, let alone the complexities of the AIDD revolution. Insilico’s journey over the past four years, defined by persistence and innovation, has been beautifully captured in these documentaries. They transform a complex, behind-the-scenes mission into engaging and relatable art. Docuthon Winner: Junyue Wang from Columbia University Insilico Presents: Coding the Impossible Cure Honorable Mention: Ekarthan Studio from India Special Award: Insilico Robotics Lab by The Afgan Dreamers You have done more than just tell our story—you have enriched it, adding new layers of perspective and emotion that resonate deeply with audiences from all walks of life. Thank you Oren Rosenfeld Amelia Martyn Hemphill Taryn Southern Alvaro Alvarez Ricciardelli Laila Kazmi for being our amazing judges! Stay tuned over the next two weeks as we release these incredible documentaries one by one. Each film delves deep into the stories behind the technology, the scientists driving innovation, and the transformative impact AI-powered drug discovery can have on global health. View More on our Website: https://lnkd.in/eY3JU2uw